VAERS Explorer
Back to explore

Report #2882679

Received Jan 21, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
FLU3INFLUENZA (SEASONAL) (FLUZONE)SANOFI PASTEURUNKU8689AAOT

Symptoms (1)

No adverse event

Symptom narrative

while a nurse was administering Fluzone to a pediatric patient, the vaccine accidentally squirted out and came into contact with the patient's mother's eye with no reported adverse event; while a nurse was administering Fluzone to a pediatric patient, the vaccine accidentally squirted out and came into contact with the patient's mother's eye with no reported adverse event; Initial information received on 14-Jan-2026 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional. This case involves an unknown age female patient and reporter stated that while a nurse was administering influenza USP trival A-B subvirion NO preservative vaccine [Fluzone] to a pediatric patient, the vaccine accidentally squirted out and came into contact with the patient's mother's eye with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, while administering the suspect influenza USP trival A-B subvirion no preservative vaccine Suspension for injection (Unknown strength and expiry date) with lot U8689AA via unknown route in unknown administration site for Prophylactic vaccination (Immunisation) to a pediatric patient, the vaccine accidentally squirted out and came into contact with the patient's mother's eye with no reported adverse event (accidental exposure to product) (exposure via eye contact) (Latency same day). Action taken: Not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.